Researcher

My Expertise

Haematology

Cellular therapy

CAR T cell therapy

Stem cell transplantation

Lymphoma

Clinical trials

Health equity

Health policy

AI in health care

Keywords

Fields of Research (FoR)

Haematology, Oncology and carcinogenesis, Health services and systems, Health equity, Health policy, Artificial intelligence

SEO tags

Biography

Prof Nada Hamad is a haematologist and clinician researcher in cellular therapy, including CAR T and stem cell transplantation. She is President and Chair of the Board of ANZTCT (Australia and New Zealand Transplant and Cellular Therapies), the peak body and national clinical quality registry for transplant and cellular therapy in Australia and New Zealand, Conjoint Professor at UNSW Sydney, Adjunct Professor at the University of Notre Dame...view more

Prof Nada Hamad is a haematologist and clinician researcher in cellular therapy, including CAR T and stem cell transplantation. She is President and Chair of the Board of ANZTCT (Australia and New Zealand Transplant and Cellular Therapies), the peak body and national clinical quality registry for transplant and cellular therapy in Australia and New Zealand, Conjoint Professor at UNSW Sydney, Adjunct Professor at the University of Notre Dame Australia and a Fulbright Senior Scholar.

Her research looks at access to and outcomes of advanced therapies, using real world data to show where health systems fall short and how to close those gaps. Her focus areas are lymphoma, clinical trials, health equity, health policy and AI in health care. She has published in journals including the New England Journal of Medicine, Nature Medicine, JAMA, Journal of Clinical Oncology, Lancet Haematology and Blood, and has been a Chief Investigator on more than $4 million in competitive research funding.

She is the Australian representative on the WHO Bone Marrow Transplantation Taskforce and an Associate Editor of JCO Global Oncology. She supervises ILP, Honours and HDR students and is committed to mentoring the next generation of clinician researchers.


My Grants

Chief Investigator

  • CIRCUIT: Comparison of immunity boosting regimens for COVID-19 upon initiation of immunosuppressive therapy. MRFF, $2,688,736, 2021 to 2026
  • MoST-LLy: Molecular Screening and Therapeutics in Leukaemia and Lymphoma. MRFF, 2021 to 2026
  • RESELECT: Rescuing bone marrow function in patients with aplastic anaemia and bone marrow failure after allogeneic transplantation. MRFF and Maddie Riewoldt's Vision, $1,122,000, 2020 to 2024
  • COPE: Cancer and Outcomes in Pregnancy, a NSW Evaluation. Cancer Council NSW, $445,384, 2018 to 2020
  • An integrated immunology and bone marrow transplant program for genetic immune deficiency disorders. St Vincent's Clinic Foundation, $50,000, 2021
  • SeroOzNet: COVID-19 vaccination in immunocompromised patients. Leukaemia Foundation, $30,000 (national project funded by Cancer Australia)
  • Disease specific outcome reporting from the ANZTCT registry. Arrow Foundation, $25,000, 2023
  • Disease specific outcome reporting from the ABMTRR. Leukaemia Foundation, $15,000, 2019
  • CORIA: Coronavirus Outcomes Registries in Immunocompromised Individuals Australia

My Qualifications

BSc, MSc Forensic (Hons), MBBS (Hons), FRACP, FRCPA, FRCP, FRCPE, AFRACMA, GAICD, GAICG

  • Certificate, AI in Health Care: From Strategies to Implementation, Harvard, 2026
  • Graduate, Australian Institute of Clinical Governance (GAICG), 2025
  • Fellow, Royal College of Physicians of Edinburgh (FRCPE), 2024
  • Graduate, Australian Institute of Company Directors (GAICD), 2024
  • Fellow, Royal College of Physicians UK (FRCP), 2023
  • Associate Fellow, Royal Australasian College of Medical Administrators (AFRACMA), 2023
  • Master Certified Physician Development Coach, Physician Coaching Institute, 2022
  • Specialist Certificate in Clinical Research (Oncology), University of Melbourne, 2015
  • Allogeneic Bone Marrow Transplantation and Lymphoma Fellowships, University of Toronto, 2013
  • FRACP, Royal Australasian College of Physicians, 2012
  • FRCPA, Royal College of Pathologists of Australasia, 2012
  • MBBS (Hons), The University of Sydney, 2004
  • MSc Forensic (Hons), The University of Auckland, 2000
  • BSc (Pharmacology and Physiology)

My Awards

  • 2025 Fulbright Senior Scholar Award
  • 2024 UNSW Publication Award
  • 2024 UNSW Conferred Academic Titleholder Engagement Award: Collegiality, Engagement and Leadership
  • 2023 Female Champion of the Year, St Vincent's Hospital Sydney
  • 2023 Finalist, St Vincent's Health Australia Awards, Individual category
  • 2022 Faculty of Medicine and Health Publication Award, UNSW
  • 2022 Faculty of Medicine and Health Education Innovation Team Award, UNSW (sexual assault and domestic and family violence curriculum)
  • 2020 Faculty of Medicine and Health Education Award, UNSW
  • 2020 Conjoint Teacher of the Month, UNSW
  • 2019 Digital Innovations Award, St Vincent's Hospital Sydney
  • Seven American Society of Hematology Abstract Achievement Awards (2013 to 2022)
  • Two Top Cited Article Awards and an Editor's Choice Award, Internal Medicine Journal
  • 2015 ALLG Education Scholarship

My Research Activities

  • Access to and outcomes of cellular therapy, including CAR T cell therapy
  • Allogeneic and autologous stem cell transplantation
  • Lymphoma
  • Clinical trials in haematological malignancies
  • Real world data and clinical quality registries
  • Health equity, health disparities and intersectionality
  • Health policy
  • AI in health care
  • Haematological malignancies in pregnancy

My Research Supervision


Supervision keywords


Areas of supervision

  • Independent Learning Project (ILP)
  • Honours
  • Higher degree research (PhD and Masters)

Currently supervising

  • ILP and Honours students in haematology, cellular therapy and health equity research
  • PhD co-supervision: intersectionality in female leadership in medicine in Australia (University of Melbourne)

My Engagement

  • President and Chair of the Board, Australia and New Zealand Transplant and Cellular Therapies (ANZTCT)
  • Australian representative, WHO Bone Marrow Transplantation Taskforce
  • Member, Human Haemopoietic Progenitor Cells Working Group, Australian Commission on Safety and Quality in Health Care
  • Associate Editor, JCO Global Oncology
  • Board Director, Australian Sickle Cell Advocacy
  • Deputy Co-Chair, UNSW Medicine Equity, Diversity and Inclusion Committee
  • Equity, Diversity and Inclusion Advisor, Lancet Haematology
  • Immediate past Chair, NSW ACI Bone Marrow Transplant Network and ALLG Transplant and Cellular Therapies group

My Teaching

  • Haematology rotation supervisor, UNSW Medicine (2016 to present)
  • Curriculum design and delivery: intersectionality in medicine, and sexual assault and domestic and family violence, UNSW Faculty of Medicine and Health (2019 to present)
  • Co-Chair, Health Equity and Patient Advocacy theme, UNSW Medicine program redesign
  • Examiner: OSCE, quality use of medicines and final year portfolio vivas
  • Associate Professor progression panel member, UNSW (2021 to present)
View less

Location

School of Clinical Medicine, UNSW Sydney

Contact

02 83821111

Videos

Why access to stem cell transplantation and cellular therapy is still unequal around the world, and what health systems can do about it.
Interview on her path in haematology, bone marrow transplantation and clinical research, and on women in medicine.
Arrow Foundation Transplant Talk webinar explaining how CAR T cell therapy works and who it can help.
Power Of Women Podcast conversation on speaking up, leadership and listening to women in medicine.
The Graft Podcast (EBMT Trainees) on equity, diversity and access in transplant training and care.
EBMT International Women's Day interview on women in haematology and transplantation.
Equitable access to transplant and cellular therapy worldwide
Women in medicine
CAR T cell therapy: the basics
What happens when women take the lead?
Access and diversity in training and health care
International Women's Day interview